Oxytocin Buy
High-purity Oxytocin acetate is an essential nonapeptide for neuroendocrine, behavioral, and signal transduction research. When evaluating where to execute an oxytocin buy for academic or industrial research, laboratories require verified chemical identity, strict purity testing, and batch-to-batch consistency. PX1 Research supplies USA-manufactured research-grade peptides accompanied by full lot-specific analytical documentation.
Quick answer
High-purity Oxytocin acetate is an essential nonapeptide for neuroendocrine, behavioral, and signal transduction research. When evaluating where to execute an oxytocin buy for academic or industrial research, laboratories require verified chemical identity, strict purity testing, and batch-to-batch consistency. PX1 Research supplies USA-manufactured research-grade peptides accompanied by full lot-specific analytical documentation.
Key takeaways
- To execute an authentic [oxytocin](/research-peptides/oxytocin) buy for laboratory experimentation, procurement specialists and primary investigators must select suppliers providing verified research-grade material (>98% purity).
- [Oxytocin](/research-peptides/oxytocin) is an endogenous mammalian nonapeptide (C43H66N12O12S2) characterized by a cyclic structure formed by a disulfide bridge between Cys1 and Cys6 residues, terminated by a tripeptide tail (Pro-Leu-Gly-NH2).
- The primary biological target of [Oxytocin](/research-peptides/oxytocin) is the Oxytocin Receptor (OXTR), a Class A Rhodopsin-like G-Protein Coupled Receptor (GPCR).
- In preclinical literature, [Oxytocin](/research-peptides/oxytocin) is extensively investigated across neurobiological, behavioral, and metabolic research paradigms.
Procuring Research-Grade Oxytocin for Preclinical Protocols
To execute an authentic oxytocin buy for laboratory experimentation, procurement specialists and primary investigators must select suppliers providing verified research-grade material (>98% purity). Research-grade Oxytocin is supplied exclusively as a lyophilized powder for in vitro assays and animal model investigation, accompanied by lot-specific analytical reports including RP-HPLC, Mass Spectrometry, and endotoxin testing.
Sourcing nonapeptides for formal investigation requires stringent control over chemical synthesis and post-purification processing. Substandard material containing truncation sequences or heavy metal residues can confound experimental data, alter receptor binding kinetics, or trigger non-specific cellular responses in preclinical models. Researchers seeking to buy Oxytocin for rigorous research applications must prioritize analytical transparency over raw cost.
PX1 Research maintains a specialized supply chain designed for institutional laboratories, offering fully traceable, USA-manufactured compounds. Accessing our comprehensive catalog of research peptides allows researchers to integrate high-purity signaling molecules into standardized biochemical protocols with absolute confidence in lot reproducibility.
Molecular Structure and Biochemical Profile of Oxytocin
Oxytocin is an endogenous mammalian nonapeptide (C43H66N12O12S2) characterized by a cyclic structure formed by a disulfide bridge between Cys1 and Cys6 residues, terminated by a tripeptide tail (Pro-Leu-Gly-NH2). The complete amino acid sequence is Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2. The intramolecule disulfide bond is critical for tertiary conformation and subsequent receptor interaction.
In cell-free and structural biology models, the secondary structure of Oxytocin displays a constrained beta-turn that exposes specific side-chain functional groups to target domain residues on the oxytocin receptor (OXTR). Modifications to any amino acid within this sequence, such as deamidation or oxidation of the disulfide bridge, severely diminish binding affinity and biological activity.
When purchasing raw peptides, researchers must ensure that the synthesized material matches the exact theoretical molecular weight of 1007.19 Da. Mass spectrometry verification confirms that no sequence errors, incomplete coupling steps, or unwanted protecting group adductions remain in the finished research compound.
Primary Receptor Targets and Signal Transduction Pathways
The primary biological target of Oxytocin is the Oxytocin Receptor (OXTR), a Class A Rhodopsin-like G-Protein Coupled Receptor (GPCR). Preclinical receptor binding assays indicate that upon ligand engagement, OXTR preferentially couples to Gq/11 alpha subunits, initiating a cascade mediated by phospholipase C-beta (PLC-beta).
This signaling cascade hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the rapid release of intracellular calcium ion (Ca2+) stores from the lumen of the endoplasmic reticulum, while DAG activates protein kinase C (PKC) isoforms. In rodent tissue preparations, this transient elevation of intracellular calcium mediates contractile events and downstream gene expression profiles.
In secondary signaling pathways, OXTR activation has been observed in vitro to recruit Gi/o and Gs proteins depending on receptor density, lipid microdomain localization, and ligand concentration. Downstream activation of the mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) pathways links OXTR engagement to long-term cellular adaptation and nuclear transcription signaling.
Overview of Preclinical Literature and Experimental Models
In preclinical literature, Oxytocin is extensively investigated across neurobiological, behavioral, and metabolic research paradigms. Rodent models utilizing central or peripheral administration protocols have clarified the compound's involvement in social recognition, anxiety-like behaviors, maternal bonding mechanisms, and stress response modulation along the hypothalamic-pituitary-adrenal (HPA) axis.
In vitro data indicate that Oxytocin signaling extends beyond central nervous system tissue. Researchers studying cardiovascular preparations have documented OXTR expression in cardiac myocytes and vascular endothelial cells, where ligand binding modulates nitric oxide (NO) synthase activity and atrial natriuretic peptide (ANP) release.
Furthermore, metabolic research models focus on the role of Oxytocin in adipose tissue regulation and glucose homeostasis. Preclinical studies suggest that central administration in rodent models influences energy expenditure, lipid oxidation, and systemic insulin sensitivity, positioning this nonapeptide as a focal point in metabolic disease signaling pathways. Detailed papers on these mechanisms can be found in our peptide research library.
Comparative Neuropeptide Analysis: Oxytocin, Vasopressin, and PT-141
When designing neuropeptide signaling protocols, investigators frequently compare Oxytocin to structural homologs and functional analogs within the neuroendocrine system. Oxytocin shares significant sequence homology with arginine vasopressin, differing by only two amino acids (position 3 and position 8). While Oxytocin contains Isoleucine at position 3 and Leucine at position 8, Vasopressin contains Phenylalanine and Arginine, respectively. This subtle chemical shift dramatically alters receptor selectivity, shifting primary binding from OXTR to V1a, V1b, and V2 receptors.
In contrast to endogenous nonapeptides, synthetic central nervous system signaling modulators such as PT-141 (Bremelanotide) engage distinct receptor families—specifically melanocortin receptors (MC3R and MC4R)—to drive downstream behavioral pathways without binding OXTR. Similarly, the synthetic heptapeptide Selank acts primarily through the GABAergic system and enkephalin degradation pathways, providing an alternative axis for studying central stress responses.
Understanding these distinct receptor profiles enables researchers to select the precise peptide ligand required to isolate specific physiological pathways without off-target crosstalk during in vitro or animal model experiments.
Reconstitution, Solubilization, and Laboratory Handling Standards
Oxytocin is supplied as a sterile, lyophilized cake or powder to preserve peptide bond stability during transport. For laboratory benchwork, proper reconstitution protocols are mandatory to prevent aggregation, degradation, or bioburden contamination prior to assay execution.
Lyophilized Oxytocin demonstrates high solubility in aqueous buffers. Standard laboratory practice dictates reconstituting the powder in sterile, deionized water or phosphate-buffered saline (PBS, pH 7.4). For assays requiring long-term liquid storage, the use of sterile 0.9% sodium chloride or bacteriostatic water containing 0.9% benzyl alcohol is recommended to inhibit microbial growth.
To reconstitute, allow the glass vial to equilibrate to room temperature before introducing the solvent along the inner glass wall. Gently swirl or invert the vial until complete dissolution is observed. Violent agitation, vortexing, or sonicating must be avoided, as mechanical shear stress can disrupt delicate peptide secondary structures and induce aggregation.
Chemical Stability and Cold-Chain Storage Guidelines
In its lyophilized form, Oxytocin acetate remains stable when stored at -20°C in a manual defrost freezer, protected from light and moisture. Under these conditions, the chemical integrity and purity specifications are maintained for extended periods as indicated by expiration data on the COA.
Once reconstituted into aqueous solution, the peptide becomes significantly more susceptible to hydrolytic cleavage and oxidation, particularly at elevated temperatures or extreme pH levels. Reconstituted stock solutions should be aliquoted into single-use polypropylene microtubes to eliminate repeated freeze-thaw cycles, which degrade peptide purity.
Working aliquots should be stored at 2°C to 8°C for short-term experimentation (under 7 days) or at -80°C for long-term storage (up to 6 months). Laboratories requiring large quantities for ongoing longitudinal studies can establish bulk laboratory accounts to ensure consistent lot sourcing and scheduled cold-chain delivery.
Quality Assurance: Evaluating COA, HPLC, and Mass Spectrometry
A rigorous analytical profile is mandatory when completing an oxytocin buy for experimental research. Relying on unverified suppliers exposes laboratories to structural impurities, variable concentrations, and residual reagents from solid-phase peptide synthesis (SPPS).
Every batch of Oxytocin produced for PX1 Research undergoes independent, third-party laboratory verification. Purity is established using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). The resulting chromatogram must display a single sharp peak representing the target nonapeptide, with an integrated peak area confirming ≥98% purity, free from truncated sequence contaminants.
Identity verification is performed via Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF. The analytical report must show a dominant mass-to-charge ratio corresponding strictly to the theoretical molecular weight of Oxytocin acetate. Any batch failing to meet these strict analytical thresholds is rejected immediately.
Endotoxin Control and Bioburden Testing in Research Compounds
For cell culture assays, primary tissue cultures, and animal model protocols, bacterial endotoxin contamination poses a critical threat to experimental validity. Lipopolysaccharides (LPS) derived from Gram-negative bacterial cell walls can activate Toll-like Receptor 4 (TLR4), triggering inflammatory cytokine cascades that completely mask or distort the physiological effects of the target nonapeptide.
PX1 Research enforces strict bioburden controls across all synthesis and lyophilization steps. Finished lots undergo quantitative Chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm that endotoxin levels remain below stringent research thresholds (<0.01 EU/μg).
By enforcing low endotoxin limits alongside GMP-compliant manufacturing practices, PX1 Research delivers peptides that ensure reliable, reproducible data across sensitive neuropeptide research compounds investigations.
Why Research Facilities Source Oxytocin from PX1 Research
PX1 Research is an established USA-based supplier dedicated exclusively to serving academic institutions, biotechnology firms, and contract research organizations (CROs). We do not produce or distribute consumer products; our entire operation is tailored to scientific rigor and procurement compliance.
Key differentiators of PX1 Research include USA-manufactured synthetic peptides, lot-specific third-party COAs downloadable directly from our portal, ISO 17025 accredited analytical testing, and same-day dispatch from our California and Arizona fulfillment hubs for orders placed Monday through Friday.
When your team requires consistent, ultra-pure Oxytocin acetate for critical laboratory protocols, partnering with PX1 Research guarantees full transparency, superior chemical fidelity, and uninterrupted supply integrity.
Frequently Asked Questions
What is the purity specification for PX1 Research Oxytocin?
PX1 Research Oxytocin is synthesized to a minimum analytical purity of ≥98%, as verified by lot-specific Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) testing.
How should lyophilized Oxytocin be stored upon receipt?
Lyophilized Oxytocin should be stored at -20°C in a dry, dark environment upon arrival. Upon receipt, desiccated storage prevents moisture accumulation and maintains peptide stability.
Which solvents are recommended for reconstituting Oxytocin in lab assays?
Sterile deionized water, phosphate-buffered saline (PBS, pH 7.4), or 0.9% sterile saline are recommended. For extended liquid stability, 0.9% benzyl alcohol (bacteriostatic water) may be utilized.
What analytical testing methods are performed on each batch?
Each lot undergoes mass spectrometry (ESI-MS or MALDI-TOF) for molecular mass identity verification, RP-HPLC for chemical purity determination, and LAL chromogenic assays for endotoxin quantification.
Is PX1 Oxytocin suitable for human clinical administration?
No. PX1 Research compounds are sold strictly for in vitro, biochemical, and preclinical laboratory research. They are explicitly not for human or veterinary medical use, clinical trials, or therapeutic administration.
What is the difference between Oxytocin and Vasopressin in receptor affinity?
Oxytocin selectively targets the Gq-coupled OXTR receptor, whereas Vasopressin primarily engages V1a, V1b, and V2 receptors due to structural amino acid differences at positions 3 and 8.
How are endotoxin levels quantified for research compounds?
Endotoxin levels are quantified using a quantitative Limulus Amebocyte Lysate (LAL) assay, ensuring levels remain below <0.01 EU/μg to prevent non-specific immune activation in cell cultures or animal models.
What shipping options and lead times are available for laboratory orders?
Orders placed Monday through Friday before cut-off ship the same day from our CA and AZ facilities via expedited courier services to ensure rapid delivery to research institutions.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.